Cambridge Investment Research Advisors
SNTH

Cambridge Investment Research Advisors’s MRP SynthEquity ETF SNTH Stock Holding History

Cambridge Investment Research Advisors’s Portfolio SNTH Stock Details SNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.71M Buy
+57,459
New +$1.67M ﹤0.01% 1689

Other funds holding SNTH

IFG
Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return
KWA
Kingswood Wealth Advisors San Diego, California $2.48B AUM 36.19% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
TPWA
TRUE Private Wealth Advisors Salem, Oregon $1.16B AUM 36.18% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return
IWN
Independent Wealth Network Urbandale, Iowa $393M AUM 30.08% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
SB
Strategic Blueprint Atlanta, Georgia $2B AUM 27.02% 1-Year Est. Return
CCFM
Clear Creek Financial Management Silverdale, Washington $1.56B AUM 31.02% 1-Year Est. Return
MW
MBL Wealth Charlotte, North Carolina $1.47B AUM 19.75% 1-Year Est. Return

Cambridge Investment Research Advisors's SNTH Position: Q2 2026 in Review

Cambridge Investment Research Advisors opened a new position in MRP SynthEquity ETF (SNTH) in Q2 2026: 57,459 shares worth $1.71M. The stake represents ﹤0.01% of the portfolio and ranks #1689 among its holdings.

16 funds tracked by Wall St. Rank hold SNTH as of Q2 2026.

  • Cambridge Investment Research Advisors held 57,459 shares of MRP SynthEquity ETF worth $1.71M as of Q2 2026.
  • MRP SynthEquity ETF was a new Cambridge Investment Research Advisors position in Q2 2026.
  • MRP SynthEquity ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1689 holding.
  • 16 funds tracked by Wall St. Rank held MRP SynthEquity ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.